RT @neo_papers: Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of premat…
RT @neo_papers: Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of premat…
Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants #NeoPapers #neoTwitter https://t.co/OuB2CBpbbK
Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants #NeoPapers #neoTwitter https://t.co/bopiiBTe1P
Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants #NeoPapers #neoTwitter https://t.co/Zeu8OUO8ZH
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants #NeoPapers #neoTwitter https://t.co/qmvyplYH6v
RT @Atul_Monash: CORD-SaFe https://t.co/jcHU26sbEF is one of the ongoing studies picked up by this @CochraneNeonate #SRMA led by @MBrusch…
CORD-SaFe https://t.co/jcHU26sbEF is one of the ongoing studies picked up by this @CochraneNeonate #SRMA led by @MBruschettini Watch this space 👀, #neoTwitter! @LindsayDZhou @Neo_CellTherapy
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
RT @CochraneNeonate: - 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or…
- 3 ongoing studies, sample size 20 to 200, administer either autologous cord blood mononuclear cells intravenously or mesenchymal stem/stromal cell (intracerebroventricular injection) to preterm infants - 9 phase 1 trials Link to the review: https://t.c